A podcast providing clinical pearls and insight from experts in the field, plus the top headlines in pulmonary and critical care medicine.
In this episode, Serpil Erzurum, MD, draws on her vast experience at health care systems across the country to discuss the importance of compassion as a mentor and trainee when paving the path for others, breaking the cycle of self-doubt and learning from disappointment and failure in our careers.
Serpil Erzurum, MD, is the chief research and academic officer at the Cleveland Clinic. She is also the chair of Lerner Research Institute.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj and Erzurum report no relevant financial disclosures.
We all will be at the receiving end of critical illness for ourselves or our loved ones. It is almost guaranteed. A family’s needs are the blind spot of the overstretched and dysfunctional health care system that needs to be addressed. Here, Kristin Flanary, also known as Lady Glaucomflecken, shares her experience, hoping to highlight the challenges of the families who are at the revived end of critical illness for their loved one.
Take-home lessons for health care professionals: While clinical excellence and focus on the patient is an absolute given, what sets a great HCP apart is clear and frequent communication, empathy and kindness. Let’s do better.
Kristin Flanary, MA, is administrator and communications manager at Belin-Blank Center for Gifted Education & Talent Development at the University of Iowa.
To read Flanary’s article in Journal of Cardiac Failure, click here: https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2821%2900403-6.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. You can follow Kristin Flanary on Twitter @LGlaucomflecken.
Disclosures: Bhardwaj and Flanary report no relevant financial disclosures.
Kristin B. Highland, MS, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.
Kristin B. Highland, MS, MD, is fellowship trained in both pulmonary/critical care and rheumatology and is the respiratory institute research officer and associate program director for research and scholarship at the Cleveland Clinic.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
In this episode, E. Wes Ely, MD, MPH, discusses the value of human connection with patients, reflects on the values of hope and mercy in patient care, and reads key excerpts from his book, Every Deep-Drawn Breath.
Wes Ely, MD, MPH, is professor of medicine and critical care at Vanderbilt University Medical Center and associate director of aging research at VA Tennessee Valley Geriatric Research and Education Clinical Center.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. You can reach Dr. Ely on Twitter @WesElyMD.
Disclosures: Bhardwaj reports no relevant financial disclosures. Ely is author of Every Deep-Drawn Breath.
In this episode, Bhardwaj’s mentor, Benjamin S. Abella, MD, MPhil, FACEP, FAHA, discusses the importance of a strong mentor-mentee relationship, his path into internal and emergency medicine training and much more.
Benjamin S. Abella, MD, MPhil, FACEP, FAHA, is the professor and vice chair of research at University of Pennsylvania’s Department of Emergency Medicine. He directs the Center for Resuscitation Science and the Penn Acute Research Collaboration at the University.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. You can reach Abella on Twitter @benjaminabella.
Disclosures: Abella reports receiving honoraria from Becton Dickinson, Stryker and Zoll; research fees from Becton Dickinson, NIH and PCORI; and ownership in MD Ally and VOC Health. Bhardwaj reports no relevant financial disclosures.
This week, FDA advisory committee unanimously recommends Moderna booster shot; the USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older; FDA permits marketing of new e-cigarette products; and more.
Read the full coverage here:
FDA advisory committee unanimously recommends Moderna booster shot
USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older
FDA permits marketing of new e-cigarette products, marking first authorization of its kind
More than half of COVID-19 survivors experience symptoms 6 months after recovery
FDA issues new guidance on sodium, calls it ‘pivotal’ moment in US health
References:
FDA Press Release
USPSTF Statement
Press Release
Groff D, et al. JAMA Network Open. 2021;doi:10.1001/jamanetworkopen.2021.28568.
FDA Conference Call
This week, use of systemic corticosteroids is linked with worse covid-19 outcomes; an investigational antiviral drug reduces risk for hospitalization and death by about 50% in patients with COVID-19; Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA; and more.
Read the full coverage here:
Use of systemic corticosteroids linked with worse COVID-19 outcomes
Antiviral reduces risk for hospitalization, death by about 50% in patients with COVID-19
Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA
Unlike flu, cold viruses persisted during pandemic, study finds
AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic disease
References:
Yochai A, et al. Asthma treatment: clinical and translational science. Presented at: European Respiratory Society International Congress; Sept. 5-8, 2021 (virtual meeting).
Press Release
Press Release
Rankin, DA, et al. Abstract 154. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).
Sobieszczyk M, et al. Abstract LB6. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).
Eduardo Mireles-Cabodevila, MD, is an internationally renowned "Guru of Mechanical Ventilation and Neuromuscular Disease." He is also a fearless leader in the ICU. In this episode, he shares his journey into medicine and how he developed the “10 commandments” of fellowship research.
Eduardo Mireles-Cabodevila, MD, is the director of the Medical Intensive Care Unit and medical director of the Simulation and Advanced Skills Center at the Cleveland Clinic.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj and Mireles-Cabodevila report no relevant financial disclosures.
In this episode, Atul C. Mehta, MB, BS, discusses his path to become a physician, his early struggles once he arrived in the United States and some of the changes he’s witnessed in how bronchoscopies are performed.
Atul C. Mehta, MB, BS, is professor of medicine, Lerner College of Medicine; endowed chair in lung transplantation, Cleveland Clinic and founder and president of the American Association of Bronchoscopy.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj and Mehta report no relevant financial disclosures.
This week, symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection; US to offer booster shots to fully vaccinated Americans starting Sept. 20; CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers; and more.
Read the full coverage here:
Symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection
US to offer booster shots to fully vaccinated Americans starting Sept. 20
CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers
Vegan diet provides most health benefits among plant-based eating patterns
Dexamethasone may be ‘underused’ among critically ill patients with COVID-19
References:
Debes AK, et al. JAMA Intern Med. 2021;doi:10.1001/jamainternmed.2021.4580.
Press Conference
Crippa JAS, et al. JAMA Netw Open. 2021;doi:10.1001/jamanetworkopen.2021.20603.
Jardine M, et al. D-18. Presented at: ADCES21; Aug. 12-15, 2021 (virtual meeting).
Mehta HB, et al. 2021;doi: Ann Intern Med. doi:10.7326/M21-0857.
This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.
Read the full coverage here:
Single-use bronchoscope receives FDA clearance
Moderna COVID-19 vaccine safe, efficacious in adolescents
Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study
FDA allows third dose of COVID-19 vaccine for immunocompromised patients
CMS nixes 'most-favored nation' pricing model for Medicare Part B
References:
Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.
CMS proposed rule.
Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.
Press Release.
Press Release.
This week, the CDC confirms a fatal case of melioidosis in Georgia; Moderna says its vaccine is 93% effective at 6 months; a survey shows patients prefer that physicians wear white coats; and more.
Read the full coverage here:
CDC confirms fatal case of melioidosis in Georgia, links it to previous US cases
Moderna COVID-19 vaccine 93% effective, ‘durable’ at 6 months, company says
Casual attire is becoming more popular among physicians, but patients prefer white coats
Modified Mediterranean-ketogenic diet may reduce cognitive decline
Coexistence of bronchiectasis with asthma, chronic rhinosinusitis common
References:
Kawas MI, et al. Modified Mediterranean Ketogenic diet resolves default node network connectivity differences between adults with normal and impaired cognition: A pilot study. Presented at: Alzheimer’s Association International Conference; July 26-30, 2021 (virtual meeting).
Press Release.
Press Release.
Sheng H, et al. BMC Pulm Med. 2021;doi:10.1186/s12890-021-01575-7.
Xun H, et al. JAMA Netw Open. 2021;doi:10.1001/jamanetworkopen.2021.17779.
This week, Pfizer says a third dose of the vaccine boosts protection, even against the delta variant; US News and World Report ranks Mayo Clinic number 1 for pulmonology and lung surgery; the FDA approves IV selexipag for adults with PAH; and more.
Read the full coverage here:
Pfizer says third dose of vaccine boosts protection, including against delta variant
CDC alters mask guidance, says even vaccinated Americans need them in some places
Mayo Clinic ranked No. 1 hospital in US for pulmonology, lung surgery
FDA approves selexipag for IV use in adults with PAH
FDA approves Saphnelo, first new lupus treatment since 2011
References:
AstraZeneca press release.
Lupus Research Alliance press release.
Pfizer. Second quarter 2021 earnings teleconference. July 28, 2021. https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf. Accessed on July 28, 2021.
Press Conference.
Press Release.
U.S. News & World Report.
This week, CHEST issues guidelines for low-dose CT screening for lung cancer; severe COVID-19 survivors experience pulmonary impairment; the FDA approves Prograf to prevent lung transplant rejection; and more.
Read the full coverage here:
CHEST issues new guideline on benefits, harms, use of low-dose CT screening for lung cancer
Pulmonary impairment ‘highly prevalent’ in severe COVID-19 survivors following discharge
FDA approves Prograf to prevent organ rejection in lung transplant recipients
In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA
Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care’
References:
González J, et al. Chest. 2021;doi:10.1016/j.chest.2021.02.062.
Khan SU, et al. eClinical Medicine. 2021;doi:10.1016/j.eclinm.2021.100997.
Mazzone PJ, et al. Chest. 2021;doi:10.1016/j.chest.2021.06.063.
Press Release.
Sholzberg M, et al. medRxiv. 2021;doi:10.1101/2021.07.08.21259351.
In this episode, the original “zentensivisit” Matt Siuba, DO, sits down with me to discuss the concept of zentensivism, tips for social media, and much more. Don’t miss his top critical care papers every fellow should know.
Matt Siuba, DO, is an intensivist at the Cleveland Clinic. His interests include circulatory shock as well as severe forms of respiratory failure, especially acute respiratory distress syndrome. He is invested in zentensivism: minimally invasive, maximally attentive medical care. Siuba is enrolled in the M.S. in Clinical Research program at Case Western Reserve University.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. Dr. Siuba can be reached on Twitter @msiuba.
Disclosures: Bhardwaj and Siuba report no relevant financial disclosures.
This week, surging caseloads are linked to nearly one quarter of US COVID-19 deaths; booster doses may not be necessary for the Pfizer vaccine; the FDA calls for an investigation into the recent Alzheimer’s drug approval; cancer death rates continue to decline; and frailty is tied to longer mechanical ventilation.
Read the full coverage here:
23% of COVID-19 deaths at US hospitals linked to surging caseloads
CDC, FDA say booster doses not needed as Pfizer eyes authorization
FDA calls for a federal investigation into Aduhelm approval
Declines in cancer death rates continue, but not for all common types
Frailty tied to longer mechanical ventilation, identifies those less likely to be liberated
References:
BioNTech. Pfizer and BioNTech provide update on booster program in light of the delta-variant. https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-provide-update-booster-program-light-delta. Accessed on July 9, 2021.
HHS. Joint CDC and FDA statement on vaccine boosters. https://www.hhs.gov/about/news/2021/07/08/joint-cdc-and-fda-statement-vaccine-boosters.html. Accessed on July 9, 2021.
Islami F, et al. J Natl Cancer Inst. 2021;doi:10.1093/jnci/djab131.
Kadri SS, et al. Ann Intern Med. 2021;doi:10.7326/M21-1213.
Okahara S, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202102-178OC.
STAT. FDA calls for federal investigation into its controversial Alzheimer’s drug approval. Available at: https://www.statnews.com/2021/07/09/fda-investigation-alzheimers-drug-approval/?utm_source=STAT+Newsletters&utm_campaign=972fd2c048-breaking_COPY_01&utm_medium=email&utm_term=0_8cab1d7961-972fd2c048-151965521. Accessed July 9, 2021.
This week, low-dose azithromycin did not improve cough in patients with IPF; tele-pulmonary rehab may lower barriers to care; the J&J vaccine provides 8-month protection from the delta variant; a daily ECMO liberation protocol was found to be safe and feasible; and portable air cleaners could reduce exposure to SARS-CoV-2 aerosols.
Read the full coverage here:
Study does not support low-dose azithromycin to treat chronic cough in IPF
Telehealth pulmonary rehabilitation program for COPD accessible, feasible, safe
J&J vaccine protects against delta variant for at least 8 months, studies find
ECMO-free protocol feasible, may aid earlier identification of patients for decannulation
Portable air cleaners could reduce exposure to SARS-CoV-2 aerosols, study finds
References:
Alwakeel AJ, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202006-638OC.
Gannon WD, et al. Chest. 2021;doi:10.1016/j.chest.2021.05.066.
Guler SA, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202103-266OC.
Lindsley WG, et al. MMWR Morb Mortal Wkly Rep. 2021;doi:10.15585/mmwr.mm7027e1.
This week, the FDA issues an EUA for tocilizumab in COVID-19; an electronic tool detects ovarian and pancreatic cancers; the delta variant accounts for 20% of new COVID-19 cases; researchers uncover variables linked with COVID-19 fatalities; and the ACIP recommends the dengue vaccine for children in endemic areas.
Read the full coverage here:
FDA issues EUA for tocilizumab to treat patients hospitalized with COVID-19
‘Electronic nose’ accurately detects ovarian, pancreatic cancers
Fauci: 20% of new COVID-19 cases are from delta variant
Researchers identify variables associated with COVID-19 fatalities during first wave
ACIP unanimously recommends dengue vaccine for children aged 9 to 16 years
References:
CDC. Advisory Committee on Immunization Practices. https://www.cdc.gov/vaccines/acip/index.html. Accessed June 24, 2021.
FDA press release.
Genentech press release.
Johnson ATC, et al. Abstract 9004. Presented at: ASCO Annual Meeting (virtual meeting); June 4-8, 2021.
Millar JA, et al. Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave. Presented at World Microbe Forum; June 20-24, 2021 (virtual meeting).
James Stoller, MD, MS, is chair of the Education Institute at Cleveland Clinic. His love for patient care and passion for medical education is palpable. In this episode we discuss burnout, imposter syndrome and thought leadership.
Tell me about yourself 2:04
Do you remember making an active effort to create such a positive training environment here at Cleveland Clinic? 3:26
James Stoller, MD, MS, is executive director of physician leadership development and chair of the Education Institute at Cleveland Clinic.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj and Stoller report no relevant financial disclosures.
This week, the FDA grants approval on two treatments: oral omadacycline for community-acquired bacterial pneumonia and Trikafta for children aged 6 to 11 with cystic fibrosis; more than 70% of COVID-19 patients experience at least one persistent symptom; many patients self-identify the need for pulmonary rehab following COVID-19 hospitalization; and children who had mild or asymptomatic COVID-19 do not need to be cleared for sports, according to the AAP.
Read the full coverage here:
FDA approves omadacycline oral regimen for community-acquired bacterial pneumonia
FDA approves Trikafta for children aged 6 to 11 with cystic fibrosis
More than 70% of COVID-19 patients experience at least one persistent symptom
Many patients self-identify need for pulmonary rehab following COVID-19 hospitalization
AAP: Children who had mild or asymptomatic COVID-19 do not need to be cleared for sports
This week, the ATS issued a new clinical practice guideline for noninfluenza viral pathogen testing in community-acquired pneumonia; the FDA issued two approvals: the first new Alzheimer’s treatment since 2003, as well as once-weekly semaglutide for weight loss; and Healio spoke with experts regarding the use of face masks among children, and the link between COVID-19 vaccination and tinnitus.
This week, the CDC reported that breakthrough infections are rare among the first 101 million fully vaccinated people; tai chi is found to be effective to reduce belly fat in older adults; the CDC’s COVID-19 vaccine safety group says its reviewed ‘few’ reports of myocarditis in young people; a follow-up analysis supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia; and lidocaine throat spray reduces cough frequency in patients with refractory chronic cough.
Read the full coverage here:
Breakthrough infections rare among first 101 million fully vaccinated people, CDC finds
Tai chi ‘effective approach’ in reducing belly fat in older adults
CDC’s COVID-19 vaccine safety group reviews ‘few’ reports of myocarditis in young people
Trial supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia
Lidocaine throat spray reduces cough frequency in patients with refractory chronic cough
In this episode, I sit down with Sumita Khatri, MD, director of the Asthma Center at Cleveland Clinic, to discuss unconscious bias, advocating for immigrant physicians, overcoming imposter syndrome and balancing work and family life.
Brought to you by Amgen and AstraZeneca.
Sumita Khatri, MD, MS, is a professor of medicine at Cleveland Clinic Lerner College of Medicine/Case Western Reserve University School of Medicine and an adult pulmonary and ICU physician with a specialized focus in asthma patient care and clinical research. Khatri is also the director of the Asthma Center at Cleveland Clinic and cares for patients in the Medical ICU.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj and Khatri report no relevant financial disclosures.
This week, a monoclonal antibody cocktail cut COVID-19 hospitalization and death by 70% in an outpatient setting; removing race correction in lung function tests shows more severe disease in Black patients; gefapixant reduces chronic cough frequency in a large pooled analysis; daily probiotics reduced upper respiratory tract infection symptoms; and moderate alcohol intake lowers stress-related brain activity and may reduce CVD risk.
Read the full coverage here:
Monoclonal antibody cocktail cut COVID-19 hospitalization, death by 70% in outpatient setting
Removing race correction in lung function tests shows more severe disease in Black patients
Gefapixant reduces chronic cough frequency in large pooled analysis
Probiotics, reduction in upper respiratory tract infection symptoms
Moderate alcohol intake lowers stress-related brain activity, may reduce CVD risk
Neal Chaisson, MD, is the program director of the Critical Care Medicine fellowship at Cleveland Clinic. He is an innovator at heart and a renowned clinician with expertise in pulmonary arterial hypertension associated with congenital heart disease. He is a phenomenal educator with a special interest in pulmonary hemodynamics and shock management. He is an outstanding proceduralist and fellows love him for his procedure teaching skills. Listen to his inspiring journey and learn how he is able to do justice to all the different roles he plays at work and in life.
Neal Chaisson, MD, is an assistant professor of medicine and the program director of the Critical Care Medicine Fellowship in the Respiratory Institute at Cleveland Clinic.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj and Chaisson report no relevant financial disclosures.
This week, a study identifies two distinct phenotypes of COVID-19-associated ARDS; COVID-19 ‘long haulers’ face ‘substantial burden of health loss’; disparities in COVID-19 are ‘striking’ according to the director of the CDC; and some weight loss and sports supplements contain potentially harmful stimulants.
Read the full coverage here:
Study identifies two distinct phenotypes of COVID-19-associated ARDS
COVID-19 ‘long haulers’ face ‘substantial burden of health loss’
CDC director: Disparities in COVID-19 are ‘striking’
Some weight loss, sports supplements contain potentially harmful stimulants
This week, the question of whether we’ll need COVID-19 booster shots; the ACIP recommends resuming use of the J&J COVID-19 vaccine; humans in the UK transmitted SARS-CoV-2 to their cats; an NBA study shows that persistent positive cases do not transmit COVID-19 after recovery; and neurological symptoms with COVID-19 serve as an ‘important predictor’ of poor outcomes.
Read the full coverage here:
Will we need COVID-19 booster shots?
CDC advisory group recommends resuming use of J&J COVID-19 vaccine
New study demonstrates human-to-cat SARS-CoV-2 transmission
NBA study shows persistent positive cases do not transmit COVID-19 after recovery
Neurological symptoms with COVID-19 serve as ‘important predictor’ of poor outcomes
References:
Advisory Committee on Immunization Practices.
Hosie MJ, et al. Vet Rec. 2021;doi:10.1002/vetr.24.
Mack CD, et al. JAMA Intern Med. 2021;doi:10.1001/jamainternmed.2021.2114.
Paul N, et al. Acute hospital outcomes COVID-19 associated neurological dysfunction. Presented at: American Academy of Neurology Annual Meeting; April 17-22, 2021 (virtual meeting).
In this episode, we take a deep dive into the journey of a role model educator. As the program director of one of the most prestigious pulmonary and critical care medicine fellowship programs in the country, Rendell Ashton, MD, has mentored, inspired and shaped the careers of hundreds of physicians. Listen to his inspiring story of grit, passion and perseverance; we hope that afterwards you can reflect on the positive in your life, find meaning in your work and take away the message that kindness and care matter above all. #belikeRen
Rendell Ashton, MD, is program director of the Pulmonary and Critical Care Fellowship at Cleveland Clinic.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Ashton and Bhardwaj report no relevant financial disclosures.
This week, the benefits of using telemedicine to address sleep disorders and provide cystic fibrosis care; rituximab may be an effective adjuvant treatment for systemic sclerosis and PAH; the FDA says facilities should move away from crisis capacity conservation measures; and researchers call for standardization to identify and categorize environmental exposures when assessing interstitial lung disease progression.
Read the full coverage here:
American Academy of Sleep Medicine updates guidance on telemedicine for sleep disorders
Rituximab safe, potentially effective adjuvant treatment for systemic sclerosis-PAH
Clinician survey highlights benefits of telehealth for cystic fibrosis care delivery
FDA says HCP can transition away from reusing disposable respirators
Insights on identification, remediation of environmental exposures in patients with ILD
References:
Copeland CR, et al. Chest. 2021;doi:10.1016/j.chest.2021.02.021.
FDA. FDA Recommends Transition from Use of Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities. https://www.fda.gov/medical-devices/letters-health-care-providers/fda-recommends-transition-use-decontaminated-disposable-respirators-letter-health-care-personnel-and. Accessed April 9, 2021.
Perkins RC, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202012-1484RL.
Shamim-Uzzaman QA, et al. J Clin Sleep Med. 2021;doi:10.5664/jcsm.9194.
Zamanian RT, et al. Am J Respir Crit Care Med. 2021;doi:10.1164/rccm.202009-3481OC.
In this episode, host Abhishek Bhardwaj, MD, FACP, discusses his path to medicine, the differences in the Indian and United States health care systems, being on the frontlines of a pandemic, and more.
Abhishek Bhardwaj, MD, FACP, is a fellow in pulmonology and critical care medicine at the Cleveland Clinic. He is also the host of Vital Capacity.
We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.
Disclosures: Bhardwaj reports no relevant financial disclosures.
This week, gastroesophageal reflux disease may contribute to development of lung fibrosis; socioeconomic factors mediate the association of race/ethnicity with worse outcomes in COVID-19; long-term air pollution exposure may elevate risk for CV mortality in patients with COPD; and more.
Read Healio's full coverage here:
https://www.healio.com/news/pulmonology/20210324/gastroesophageal-reflux-disease-may-contribute-to-development-of-lung-fibrosis
https://www.healio.com/news/pulmonology/20210322/socioeconomic-factors-mediate-association-of-raceethnicity-with-worse-outcomes-in-covid19
https://www.healio.com/news/pulmonology/20210323/longterm-air-pollution-exposure-may-elevate-risk-for-cv-mortality-in-patients-with-copd
https://www.healio.com/news/pulmonology/20210325/cpap-adherence-varies-by-neighborhood-racial-composition
https://www.healio.com/news/pulmonology/20210325/viral-codetection-linked-with-longer-duration-of-ventilation-in-critically-ill-infants
https://www.healio.com/news/pulmonology/20210323/pulmonary-rehabilitation-confers-longterm-benefits-in-patients-with-copd
This week, people with asthma not at higher risk for poor COVID-19 outcomes; adherence to asthma biologic therapy higher than inhaled corticosteroids; health care affordability, racial disparities persist in individuals with asthma, COPD; and more.
Read Healio's full coverage here:
https://www.healio.com/news/pulmonology/20210317/people-with-asthma-not-at-higher-risk-for-poor-covid19-outcomes-study-finds
https://www.healio.com/news/pulmonology/20210319/adherence-to-asthma-biologic-therapy-higher-than-inhaled-corticosteroids
https://www.healio.com/news/pulmonology/20210315/health-care-affordability-racial-disparities-persist-in-individuals-with-asthma-copd
https://www.healio.com/news/pulmonology/20210316/study-supports-early-discharge-ambulatory-rivaroxaban-in-lowrisk-pulmonary-embolism
https://www.healio.com/news/pulmonology/20210318/lowrisk-status-achieved-or-maintained-in-minority-of-patients-on-pah-combination-therapy
Coming soon, from Healio, Vital Capacity - a pulmonary and critical care podcast bringing you clinical pearls and insight from experts in the field, plus the top headlines. Be sure to subscribe for episode alerts, and follow us on twitter @HealioPulm.